Web15 de jun. de 2024 · Among patients with bleeding, the percentage of patients who had bleeding within <36 hours did not differ by UFH dose group (39.1% vs 21.9% vs 20.5% for no UFH, low-dose and high-dose UFH, respectively; Fisher exact test P = .26). Web3 de dez. de 2024 · Results: A total of 1, adults were included in the analysis, including patients who received high-dose 7, units every 8 hours unfractionated heparin and patients who received low-dose 5, units every 8 hours unfractionated heparin. Address correspondence to Obesity chart. Select Format Select format. Submit a comment. …
Comparison of Low and Intermediate Dose Low-molecular-weight Heparin …
Web18 de out. de 2011 · The same demographic baseline data were also compared between the high-dose and low-dose arms within the RCT and cohort study, respectively . None of the baseline variables differed significantly, except for a trend towards a higher proportion of infants in the low-dose arm of the cohort study (29% vs. 13%, P = 0.09). Web27 de out. de 2014 · This was a prospective RCT of 219 patients with unstable angina randomized to aspirin, aspirin plus heparin infusion, or aspirin plus low molecular-weight heparin (high-dose nadroparin). Study therapies were continued until discharge, reaching a primary endpoint (recurrent angina, acute MI, urgent intervention, major bleeding, or … increase aptt
Unfractionated heparin (UFH), LMWH, fondaparinux, argatroban, …
Web6 de fev. de 2024 · Heparins, including unfractionated heparin and a variety of low molecular weight (LMW) heparin products, are used extensively as anticoagulants. This … Web10 de abr. de 2024 · To determine whether therapeutic anticoagulation (TA) or high-dose prophylactic anticoagulation (HD-PA) decreases mortality and/or disease duration compared with standard-dose prophylactic anticoagulation (SD-PA), and whether TA outperforms HD-PA; and to compare the net clinical outcomes among the 3 strategies. Web1 de abr. de 1997 · A weight-adjusted low dose of intravenous heparin is at least as safe as a fixed high dose for coronary angioplasty and allows earlier sheath removal and discharge to a stepdown unit. AIMS Prospectively to compare success rate and complications in percutaneous transluminal coronary angioplasty using two doses of … increase archive mailbox quota